Home › International, foreign affairs & national security
International Vaccine Institute
International Vaccine Institute reported $69.0 million in revenue and $74.3 million in expenses for calendar year 2024. Of every $100 it spent, $80.03 went to program services, $19.92 to management and general costs and $0.05 to fundraising. Its largest source of revenue was contributions and grants: 100.9% of the total. Government grants made up 18.3%. The highest compensation it reported for one person was $913,731 (DIRECTOR GENERAL). 58 people received more than $100,000 in reportable compensation. Revenue rose 120% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $74MFor context, the median across 469 covered international, foreign affairs & national security charities: $89.04 programs, $8.28 management, $2.68 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $69M- Contributions & grants (non-government)$79.81 $57M
- Government grants$17.70 $13M
- Investment income$2.49 $1.8M
Other revenue was negative: −$2.4M. The bar shows the positive sources only.
The 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 80.0% | 86.1% |
| Management & general Part IX 25(C) ÷ 25(A) | 19.9% | 8.0% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 2.6% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.03 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 100.9% | 96.6% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 18.3% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.0% | 0.0% |
| Highest reported compensation Part VII-A, columns D–F | $913,731 | $341,362 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 1.23% | 1.06% |
| People paid over $100,000 Part VII, line 2 | 58 | 10 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 15.3 | 7.5 |
| Independent voting board members Part VI 1a–1b | 19 of 20 | 100.0% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseThe phase ii component of the study is completed, and the interim clinical study report (csr) from phase ii (parts a and b) is available. Based on additional testing results of days 28 and 56 of phase 2 subgroup samples, data from nhp passive transfer study, and safety data, a final decision on the optimal dose for part c was made, and 40 ug was selected. A consortium consensus justification memo of final dose selection is completed. Protocol amendment v 5.0 containing this new information was approved by local ecs and nras. Virtual pi meetings with all sites to update program status and…
Bpcov2 project - 2024 summary of activities (reference year 2024) in 2024, the bpcov2 project advanced pre-clinical development of a next-generation pan-coronavirus mrna vaccine platform supported by cepi. Project partners (upenn, unc, uc davis, chula vrc, and ivi) focused on mrna construct design and production. Multiple mrna constructs were produced and tested, including spike variants, chimeric constructs, and vlp platforms, formulated with sm-102 to enable platform comparison
Vat0008 is a pivotal multi-country phase 3, multi-stage, modified double-blind and multi-arm study where efficacy, safety and immunogenicity of two sars-cov-2 adjuvanted recombinant protein vaccines (monovalent and bivalent) were tested as primary series and monovalent booster dose as an extension. Ivi led the effort in nepal to conduct the clinical trial including conducting the local dsmb meeting. The primary series study was initiated in july 2021. The first subject for the primary series was enrolled in september 2021. The crossover/booster phase started in january 2023. The last subject…
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| DIRECTOR GENERAL Director/trustee, officer, 40.0 hrs/week | $756,439 | $0 | $157,292 | $913,731 |
| CHIEF OPERATING OFFICER Officer, 40.0 hrs/week | $486,257 | $0 | $1,904 | $488,161 |
| SENIOR SCIENTIFIC ADVISOR Highest compensated employee, 40.0 hrs/week | $323,736 | $0 | $41,566 | $365,302 |
| DEPUTY DIRECTOR GENERAL, EPIDEMIOLOGY Officer, 40.0 hrs/week | $346,625 | $0 | $1,836 | $348,461 |
| DEPUTY DIRECTOR, GENERAL, EUROPE Officer, 40.0 hrs/week | $338,690 | $0 | $2,808 | $341,498 |
| DEPUTY DIRECTOR GENERAL, CLINICAL ASSESSMENT Officer, 40.0 hrs/week | $336,079 | $0 | $3,019 | $339,098 |
| PROGRAM DIRECTOR, CHOLERA Highest compensated employee, 40.0 hrs/week | $295,940 | $0 | $17,219 | $313,159 |
| GLOBAL HEAD, QUALITY MANAGEMENT Highest compensated employee, 40.0 hrs/week | $292,070 | $0 | $20,603 | $312,673 |
58 people received more than $100,000 in reportable compensation from International Vaccine Institute (Part VII, line 2). Compensation of current officers, directors and key employees totaled $3.5M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b20 · 19 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aNo
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 5260
- Volunteers Part I, line 621
Correct a figure or respond
Every number above is copied from International Vaccine Institute's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for International Vaccine Institute, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 International Vaccine Institute spent in 2024, $80.03 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Follow Your Dream FoundationNew York, NY · revenue $67M · programs 99.1% · FY2024
- Freedom HouseWashington, DC · revenue $69M · programs 96.6% · FY2025
- Digital Promise GlobalWashington, DC · revenue $67M · programs 88.6% · 2024
- Atlantic Council of the United StatesWashington, DC · revenue $70M · programs 83.4% · 2024
- True SojournersFranklin, TN · revenue $67M · programs 89.9% · FY2025
All international, foreign affairs & national security charities · Largest charities in
Questions people ask
How much of International Vaccine Institute's spending goes to programs?
In calendar year 2024, International Vaccine Institute reported that 80.0% of its $74.3 million in expenses went to program services, 19.9% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does International Vaccine Institute pay its top executive?
The largest total compensation International Vaccine Institute reported for one person in calendar year 2024 was $913,731, for the role of DIRECTOR GENERAL (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does International Vaccine Institute get its money?
Of $69.0 million in revenue in calendar year 2024, 100.9% came from contributions and grants (including 18.3% from government grants) and 0.0% from program service revenue (Form 990, Part VIII).
Is International Vaccine Institute a registered charity?
The IRS lists EIN 31-1621592 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))). Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202543199349303654 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202433179349304258 · read the filing
- 2022: Form 990 for calendar year 2022, object 202332989349300008 · read the filing
- 2021: Form 990 for calendar year 2021, object 202203129349301255 · read the filing
- 2020: Form 990 for calendar year 2020, object 202133139349301133 · read the filing
- 2019: Form 990 for calendar year 2019, object 202023099349300302 · read the filing
All filings for EIN 31-1621592: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.